Clinical and Hemodynamic Improvement in Pulmonary Hypertension After Switching to Sacubitril/Valsartan in Patients With Heart Failure With Preserved Ejection Fraction

Department of Cardiology, Heart, and Vascular Center Bad Bevensen, Bad Bevensen, Germany.

Correspondence: Christof Burgdorf, MD, Department of Cardiology, Heart and Vascular Center Bad Bevensen, Römstedter Straße 25, Bad Bevensen 29549, Germany (e-mail: [email protected]).

The authors report no conflicts of interest.

J. Brockmöller and S. Ivanoski have shared first authorship.

All authors were involved in the design of this study. Data acquisition, analysis, and interpretation were performed by J. Brockmöller, S. Ivanoski, L. Hundack, J.-H. Blohm, and M. Januszewski, respectively. B.A. Remppis and C. Burgdorf drafted the manuscript, and all other authors revised the article for important intellectual content. All authors provided final approval for the version to be published. All authors take full responsibility for the contents of this manuscript.

留言 (0)

沒有登入
gif